Processa Pharmaceuticals, Inc. Deferred Tax Liabilities, Net, Noncurrent
Processa Pharmaceuticals, Inc. (PCSA) had Deferred Tax Liabilities, Net, Noncurrent of $1.69 million as of 2019-09-30, per its 10-Q filed 2019-11-14.
Discontinued › Notes › Income Taxes
us-gaap:DeferredTaxLiabilitiesNoncurrent · last filed 2019-11-14
- 2019-09-30: Deferred Tax Liabilities, Net, Noncurrent $1.69M.
- 2019-06-30: Deferred Tax Liabilities, Net, Noncurrent $1.83M.
- 2019-03-31: Deferred Tax Liabilities, Net, Noncurrent $2.00M.
- 2018-12-31: Deferred Tax Liabilities, Net, Noncurrent $2.13M.
| Period end | Deferred Tax Liabilities, Net, Noncurrent |
|---|---|
| 2019-09-30 | $1.69M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $1.83M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $2.00M 10-Q · filed 2019-05-14 |
| 2018-12-31 | $2.13M 10-Q · filed 2019-11-14 |
| 2018-09-30 | $2.27M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $2.48M 10-Q · filed 2018-08-14 |
| 2018-03-31 | $2.76M 10-Q · filed 2018-05-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |